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tegies of with or without aorto-ostial coverage showed similar clinical outcomes at 2
years.
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Background: Changes in revascularization strategies and outcomes among patients
with signiﬁcant unprotected left main coronary artery (LMCA) stenosis remain largely
unknown.
Methods: A total of 2618 consecutive patients with LMCA stenosis undergoing
revascularization treatment between 1995 and 2010 were identiﬁed from ASAN
MAIN registry. Patients were classiﬁed into three periods: bare metal stent (WAVE1)
period(1995-1998), early drug-eluting stent (WAVE2) period(2003-2006), and late
drug-eluting stents (WAVE3)period (2007-2010). The major adverse cerebro-car-
diovascular events (MACCE) were deﬁned as death, myocardial infarction, repeat
revascularization, or stroke at 2-years.
Results: The major adverse cerebro-cardiovascular events (MACCE) were deﬁned as
death, myocardial infarction, repeat revascularization, or stroke at 2-years.During
study periods, 1124 patients underwent percutaneous coronary intervention (PCI) with
stent and 1494 patients underwent coronary artery bypass grafting (CABG). The
proportion of PCI signiﬁcantly increased from 35% to 52%. Among patients receiving
PCI, the risk-adjusted incidence rate of MACCE decreased from 20.18 cases per 100
person-years in WAVE1 to 6.77 cases per 100 person-years in WAVE3 (P< 0.001 for
trend). Death, the composite of death, myocardial infarction, or stroke, and repeat
revascularization were also signiﬁcantly decreased by 40%, 35%, and 46%, respec-
tively. However, among patients receiving CABG, the risk-adjusted incidence rate of
MACCE was not signiﬁcantly changed during study period. In addition, the difference
in the risk of MACCE between PCI and CABG progressively reduced (adjusted
hazard ratio [95% conﬁdence interval]: 0.33 [0.23-0.47], 0.53 [0.35-0.80], and 1.01
[0.68-1.49] from WAVE1 through WAVE3.
Conclusions: The outcomes of PCI for LMCA stenosis have signiﬁcantly improved
and PCI has successfully substituted CABGin a signiﬁcant proportion of patients with
LMCA stenosis.
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Background: The aim of this study was to assess efﬁcacy and safety proﬁle of distal
LM stenosis treatment with dedicated bifurcation BiOSS stents (Balton, Poland): inB66 JACC Vol 64/11/Suppl B jgroup I - paclitaxel-eluting BiOSS Expert and in group II - sirolimus-eluting BiOSS
LIM.
Methods: Patients with CAD or NSTE-ACS were enrolled between January 2011 and
June 2013 in three centers in Bulgaria, Poland and Spain. Decision for LM stenting
was based on Heart Team consensus. Provisional T-stenting was default strategy.
Control angiography was planned at 12 months in all patients. The primary end point
is MACE at 12 months. Here, we present 6-month clinical data from both groups and
completed angiographic data from BiOSS Expert. At the time of TCT 2014 angio-
graphic data from BiOSS LIM will be completed.
Results: There were enrolled 158 patients (62 in BiOSS Expert group and 96 in
BiOSS LIM group). The average age was 65.712.5 yrs and 19.7% were female. In
the study 17.8% of patients were with NSTE-ACS, 73.4% with hypertension, 81.4%
with dyslipidemia, 32.1% with diabetes, 39.2% with prior MI, 43.3% with prior PCI
and 17.4% with prior CABG. The mean SYNTAX score was 21.526.58. True bi-
furcations were treated in 70.1% of cases. All BiOSS stents were implanted suc-
cessfully. The nominal stent parameters were as followed: BiOSS Expert group:
4.070.26mm (proximal diameter) x 3.360.26mm (distal diameter) x 16.611.72
mm (length) and BiOSS LIM group: 3.900.4mm x 3.170.39mm x
16.812.06mm. Classical DES in side branch was implanted in 25.9% and 21.4%,
respectively. Almost 62% of procedures were done from radial access and 83% with
6F catheter. After 12 months in BiOSS Expert group angiographically-driven TLR
rate was 9.6%, whereas clinically-driven TLR was 3.2%. In BiOSS LIM group data
are pending - at 6 months there were no death or MI. In BiOSS Expert group late
lumen loss was as follows: in main vessel - 0.210.1mm, in main branch –
0.260.12mm and in side branch – 0.140.09mm.
Conclusions: Dedicated bifurcation BiOSS stents seem feasible devices with prom-
ising effectiveness and safety proﬁle in distal LM stenosis. Complete BiOSS LIM data
facilitate to answer the question if the used drug or stent design is more crucial.
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Background: Final kissing balloon inﬂation (FKBI) is a mandatory technique in un-
protected left main (ULM) revascularization with 2-stent strategy. However, there is no
consensus regarding the necessity of FKBI in single-stent strategy. Therefore, to assess
the need of FKBI for single-stent strategy in ULM lesion, we compared clinical outcome
between patients treated using single-stent strategy with FKBI and those without FKBI.
Methods: A total of 654 consecutive patients who had ULM lesion were treated using
drug-eluting stent between April 2005 and August 2010. Of these, 470 patients were
eligible in this study after exclusion of 21 patients with ostial ULM and 163 patients
treated using 2-stent strategy. In patients using single-stent strategy, 357 patients were
proceeded with FKBI (FKBI group) and 113 patients were without FKBI (no-FKBI
group). The end point of this study is the occurrence of Major Adverse Cardiovascular
Event (MACE) deﬁned as composites of all cause death, target lesion revasculariza-
tion (TLR) and MI. Furthermore, overall TLR, TLR for main branch (TLR-MB)
involving ULM to left anterior descending artery and TLR for side branch alone
(TLR-SB) involving left circumﬂex (LCx) at 1-year were evaluated.
Results: Patient and lesion characteristics were similar between the 2 groups.
Following single-stent strategy, 36 patients (8.9%) necessitated an additional bailout
stenting for ostial LCx stenosis. In the total population, the occurrence of MACE at 1
year is similar between the two groups (7.4% in the FKBI group and 11.9% in the no
FKBI group, log rank p¼0.112). The incidences of overall TLR, TLR-MB and TLR-
SB at 1 year were also similar between FKBI group vs. no-FKBI group (7.0% vs.
9.3%, p¼0.44, 2.5% vs. 4.7%, p¼0.24 and 5.0% vs.5.6%, p¼0.81, retrospectively).
Conclusions: Single-stent for ULM disease was feasible at mid-term follow-up.
However, FKBI had no impact on clinical outcome following ULM revascularization
with Single-stent strategy.
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Background: Unprotected left main coronary artery (ULMCA) stenting has been
investigated as an alternative to coronary artery bypass grafting (CABG). However,
long-term beneﬁts of PCI or CABG in patients with ULMCA disease and severe left
ventricular dysfunction (LVD) have not been established.
Methods: Between March 1992 to February 2011, a total of 213 patients with sig-
niﬁcant ULMCA disease and severe LVD (ejection fraction [EF] of 40% or less) who
underwent PCI (42 patients) or CABG (171 patients) were identiﬁed from ASAN
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